When tested in HIV-infected cells, these inhibitors inhibit HIV-1 infection without blocking gp120/CCR5 interaction [63], and presumably, these inhibitors also inhibited viral replication at steps post binding and entry. The gene discussed is CCR5; the disease is HIV-1 infection.